Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2014, Article ID 598015, 2 pages
http://dx.doi.org/10.1155/2014/598015
Editorial

Diabetic Renal Disease

1Diabetes & Endocrine Centre, Mater Dei Hospital, Msida, Malta
2Department of Medicine, University of Malta, Msida, Malta
3Centre Hospitalier Universitaire Poitiers, Endocrinology, Diabetology, Poitiers, France
4Université de Poitiers, UFR Médecine Pharmacie, Centre d’Investigation Clinique, Poitiers, France
5CHU de Poitiers, Centre d’Investigation Clinique, Poitiers, France
6Institut National de la Santé et de la Recherche Médicale, CIC1402 & U1082, Poitiers, France
7NHS Lothian, University of Edinburgh, Scotland, UK

Received 13 February 2014; Accepted 13 February 2014; Published 7 April 2014

Copyright © 2014 Stephen Fava et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. C. W. Van Dijk, K. J. Jager, B. Stengel, C. Grönhagen-Riska, T. G. Feest, and J. D. Briggs, “Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991–2000),” Kidney International, vol. 67, no. 4, pp. 1489–1499, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. R. N. Foley and A. J. Collins, “The growing economic burden of diabetic kidney disease,” Current Diabetes Reports, vol. 9, no. 6, pp. 460–465, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. A. J. Ahola, M. Saraheimo, C. Forsblom, K. Hietala, H. Sintonen, and P. Groop, “Health-related quality of life in patients with type 1 diabetes-association with diabetic complications (the FinnDiane Study),” Nephrology Dialysis Transplantation, vol. 25, no. 6, pp. 1903–1908, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. H. C. Park, H.-B. Yoon, M.-J. Son et al., “Depression and health-related quality of life in maintenance hemodialysis patients,” Clinical Nephrology, vol. 73, no. 5, pp. 374–380, 2010. View at Google Scholar · View at Scopus
  5. G. Bruno, F. Merletti, A. Biggeri et al., “Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study,” Diabetologia, vol. 48, no. 3, pp. 427–434, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. K. V. Allen and J. D. Walker, “Microalbuminuria and mortality in long-duration type 1 diabetes,” Diabetes Care, vol. 26, no. 8, pp. 2389–2391, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. T. W. C. Tervaert, A. L. Mooyaart, K. Amann et al., “Pathologic classification of diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 21, no. 4, pp. 556–563, 2010. View at Publisher · View at Google Scholar · View at Scopus